Choose your country to see the products for your location
It is estimated 1 in every 8 women will develop breast cancer in their lifetime, of which 5 to 10 percent will be hereditary. Understanding breast cancer risk and early detection are crucial to provide the best care to patients and at-risk individuals. At MRC Holland, we proudly offer a wide range of assays to help with identifying hereditary breast cancer and at-risk individuals.
MRC Holland is looking for positive samples to be used in testing and developing of our products
Effective from 1 January 2024, we will be implementing a price increase of approximately 8% on most of our products.
Join our mailing list to receive the latest information about our products, technologies and website.